BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18607348)

  • 1. The pivotal role of VEGF on glomerular macrophage infiltration in advanced diabetic nephropathy.
    Sato W; Kosugi T; Zhang L; Roncal CA; Heinig M; Campbell-Thompson M; Yuzawa Y; Atkinson MA; Grant MB; Croker BP; Nakagawa T
    Lab Invest; 2008 Sep; 88(9):949-61. PubMed ID: 18607348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy.
    Nakagawa T; Sato W; Glushakova O; Heinig M; Clarke T; Campbell-Thompson M; Yuzawa Y; Atkinson MA; Johnson RJ; Croker B
    J Am Soc Nephrol; 2007 Feb; 18(2):539-50. PubMed ID: 17202420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new mouse model resembling human diabetic nephropathy: uncoupling of VEGF with eNOS as a novel pathogenic mechanism.
    Nakagawa T
    Clin Nephrol; 2009 Feb; 71(2):103-9. PubMed ID: 19203501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncoupling of VEGF with NO as a mechanism for diabetic nephropathy.
    Nakagawa T
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S67-9. PubMed ID: 18926584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Podocyte-specific VEGF-a gain of function induces nodular glomerulosclerosis in eNOS null mice.
    Veron D; Aggarwal PK; Velazquez H; Kashgarian M; Moeckel G; Tufro A
    J Am Soc Nephrol; 2014 Aug; 25(8):1814-24. PubMed ID: 24578128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice.
    Kanetsuna Y; Takahashi K; Nagata M; Gannon MA; Breyer MD; Harris RC; Takahashi T
    Am J Pathol; 2007 May; 170(5):1473-84. PubMed ID: 17456755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imbalance of glomerular VEGF-NO axis in diabetic rats: prevention by chronic therapy with propyl gallate.
    Tian S; Gan Y; Li J; Wang L; Shen J; Liu T; Ye T; Liu H; Liu D; Deng Y; Wang W
    J Nephrol; 2011; 24(4):499-506. PubMed ID: 21425119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protease-activated receptor 2 protects against VEGF inhibitor-induced glomerular endothelial and podocyte injury.
    Oe Y; Fushima T; Sato E; Sekimoto A; Kisu K; Sato H; Sugawara J; Ito S; Takahashi N
    Sci Rep; 2019 Feb; 9(1):2986. PubMed ID: 30814628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor-receptor 1 inhibition aggravates diabetic nephropathy through eNOS signaling pathway in db/db mice.
    Yang KS; Lim JH; Kim TW; Kim MY; Kim Y; Chung S; Shin SJ; Choi BS; Kim HW; Kim YS; Chang YS; Kim HW; Park CW
    PLoS One; 2014; 9(4):e94540. PubMed ID: 24759928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. eNOS deficiency predisposes podocytes to injury in diabetes.
    Yuen DA; Stead BE; Zhang Y; White KE; Kabir MG; Thai K; Advani SL; Connelly KA; Takano T; Zhu L; Cox AJ; Kelly DJ; Gibson IW; Takahashi T; Harris RC; Advani A
    J Am Soc Nephrol; 2012 Nov; 23(11):1810-23. PubMed ID: 22997257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Enhanced Leucine-Rich
    Haku S; Wakui H; Azushima K; Haruhara K; Kinguchi S; Ohki K; Uneda K; Kobayashi R; Matsuda M; Yamaji T; Yamada T; Minegishi S; Ishigami T; Yamashita A; Ohashi K; Tamura K
    Biomed Res Int; 2018; 2018():2817045. PubMed ID: 30515388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor receptor-2 and low affinity VEGF binding sites on human glomerular endothelial cells: Biological effects and advanced glycosilation end products modulation.
    Pala L; Cresci B; Manuelli C; Maggi E; Yamaguchi YF; Cappugi P; Rotella CM; Giannini S
    Microvasc Res; 2005 Nov; 70(3):179-88. PubMed ID: 16271941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiles of glomerular endothelial cells support their role in the glomerulopathy of diabetic mice.
    Fu J; Wei C; Zhang W; Schlondorff D; Wu J; Cai M; He W; Baron MH; Chuang PY; Liu Z; He JC; Lee K
    Kidney Int; 2018 Aug; 94(2):326-345. PubMed ID: 29861058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beraprost sodium, prostacyclin analogue, attenuates glomerular hyperfiltration and glomerular macrophage infiltration by modulating ecNOS expression in diabetic rats.
    Yamashita T; Shikata K; Matsuda M; Okada S; Ogawa D; Sugimoto H; Wada J; Makino H
    Diabetes Res Clin Pract; 2002 Sep; 57(3):149-61. PubMed ID: 12126764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial cell-specific overexpression of endothelial nitric oxide synthase in Ins2Akita mice exacerbates diabetic nephropathy.
    Natarajan M; Habib SL; Reddick RL; Delma CR; Manickam K; Prihoda TJ; Werner SL; Mohan S
    J Diabetes Complications; 2019 Jan; 33(1):23-32. PubMed ID: 30424931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy.
    Hohenstein B; Hugo CP; Hausknecht B; Boehmer KP; Riess RH; Schmieder RE
    Nephrol Dial Transplant; 2008 Apr; 23(4):1346-54. PubMed ID: 18065828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glomerular VEGF resistance induced by PKCδ/SHP-1 activation and contribution to diabetic nephropathy.
    Mima A; Kitada M; Geraldes P; Li Q; Matsumoto M; Mizutani K; Qi W; Li C; Leitges M; Rask-Madsen C; King GL
    FASEB J; 2012 Jul; 26(7):2963-74. PubMed ID: 22499584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The VEGF-A inhibitor sFLT-1 improves renal function by reducing endothelial activation and inflammation in a mouse model of type 1 diabetes.
    Bus P; Scharpfenecker M; Van Der Wilk P; Wolterbeek R; Bruijn JA; Baelde HJ
    Diabetologia; 2017 Sep; 60(9):1813-1821. PubMed ID: 28620823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular and molecular aspects of diabetic nephropathy; the role of VEGF-A.
    Carranza K; Veron D; Cercado A; Bautista N; Pozo W; Tufro A; Veron D
    Nefrologia; 2015; 35(2):131-8. PubMed ID: 26300505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lowering blood pressure blocks mesangiolysis and mesangial nodules, but not tubulointerstitial injury, in diabetic eNOS knockout mice.
    Kosugi T; Heinig M; Nakayama T; Connor T; Yuzawa Y; Li Q; Hauswirth WW; Grant MB; Croker BP; Campbell-Thompson M; Zhang L; Atkinson MA; Segal MS; Nakagawa T
    Am J Pathol; 2009 Apr; 174(4):1221-9. PubMed ID: 19246639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.